Clinical trial · Observational
Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.
Comparing the Stage-for-Stage Prognosis of Patients With Cardia and Non-cardia Gastric Cancer After Operation.
NCT03895008CI-TRIAL-00039330unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To comparing the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cardia and Non-cardia gastric cancer | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Cardia gastric cancer
- description
- Cardiac gastric cancer is defined as a cancer center lies arising 2-5 cm from the gastric mucosa distal to the esophagogastric junction.
- interventionNames
- Other: Cardia and Non-cardia gastric cancer
- label
- Non-cardia gastric cancer
- description
- Non-cardia gastric cancer is defined as tumors originated from the gastric mucosa distal to the cardia.
- interventionNames
- Other: Cardia and Non-cardia gastric cancer
Primary outcomes (1)
- measure
- Disease Free Survival（DFS）
- timeFrame
- 5 years
- description
- The time from the primary operation to disease recurrence or death.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Histopathology or cytopathology proven cardia or non-cardia gastric cancer; 2. Operable gastric cancer patients: primary lesions can be completely excision, no distant metastasis; 3. Life expectancy of at least 6 months; 4. ECOG（Eastern Cooperative Oncology Group ） score 0-1; 5. Age: 18\~80 years old; 6. Normal hemodynamic indices before the recruitment (including blood cell count and liver/kidney function). For example: WBC（White blood cell count ）\>4.0×109/L; NEU（Neutrophils）\>1.5×109/L; PLT（Platelet）\>100×109/L; 7. Roughly normal cardiopulmonary function: No coronary heart disease, myocardial infarction, pulmonary heart disease, refractory hypertension; 8. Not concomitant with other uncontrollable benign diseases before the recruitment; 9. Voluntarily signed the informed consent. Exclusion Criteria: 1. Advanced gastric cancer patients with distant metastasis and inoperable ; 2. Pregnant or lactating women; 3. Patients who have no desire to participate in the study.
References
Publications (0)
Data not yet available
No reference posted for this study.